<DOC>
	<DOCNO>NCT00180349</DOCNO>
	<brief_summary>The objective study demonstrate efficacy ENDOTAK® RELIANCE™ defibrillation lead connect defibrillator cardiac resynchronization defibrillator implant 12 month .</brief_summary>
	<brief_title>Leader - Evaluation Endotak Reliance</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<mesh_term>Ventricular Fibrillation</mesh_term>
	<criteria>ICD indication accord current guideline without cardiac resynchronization therapy , implant Guidant ENDOTAK RELIANCE defibrillation lead first implant , age 18 year , able understand nature study available followup , give consent write anonymous data collection , life expectancy &gt; 1 year . device replacement without concomitant implant Reliance defibrillation lead , pregnancy birth bear age without contraception , participation another clinical study , short life expectancy due medical condition , willing sign consent form , geographically unstable defibrillator followup require per protocol , ventricular arrhythmia , treat drug surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>